Attorneys general across the country have joined in litigation related to mifepristone, a drug used for medication abortions. A case currently before the Supreme Court, FDA v. Alliance for Hippocratic Medicine, could affect access to the drug by invalidating FDA guidelines from 2016 and 2021 that loosened restrictions on prescribing and administering mifepristone.
A key